Michael Kolodziej

865 total citations
34 papers, 599 citations indexed

About

Michael Kolodziej is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Kolodziej has authored 34 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 9 papers in Public Health, Environmental and Occupational Health and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Kolodziej's work include Economic and Financial Impacts of Cancer (12 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Prostate Cancer Treatment and Research (5 papers). Michael Kolodziej is often cited by papers focused on Economic and Financial Impacts of Cancer (12 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Prostate Cancer Treatment and Research (5 papers). Michael Kolodziej collaborates with scholars based in United States, Israel and Germany. Michael Kolodziej's co-authors include Marcus A. Neubauer, J. Russell Hoverman, Roy Beveridge, Joel Bennett, Amy Goldberger, Lonny Reisman, JS Bennett, PJ Newman, Stephen K. Gruschkus and Mortimer Poncz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Ultrasound in Obstetrics and Gynecology.

In The Last Decade

Michael Kolodziej

27 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kolodziej United States 12 198 195 166 135 91 34 599
C.A. Uyl-de Groot Netherlands 12 78 0.4× 115 0.6× 258 1.6× 54 0.4× 118 1.3× 28 553
Thanh Ha Luu United States 13 46 0.2× 72 0.4× 113 0.7× 42 0.3× 34 0.4× 19 519
Anna Forsythe United States 19 57 0.3× 67 0.3× 220 1.3× 165 1.2× 151 1.7× 96 926
Sacha Satram‐Hoang United States 16 194 1.0× 88 0.5× 537 3.2× 117 0.9× 189 2.1× 48 1.0k
Dennis Cain United States 6 109 0.6× 113 0.6× 181 1.1× 66 0.5× 29 0.3× 9 834
Miguel González Vélez United States 6 176 0.9× 118 0.6× 150 0.9× 91 0.7× 18 0.2× 18 430
J.M. Jonker Netherlands 6 52 0.3× 98 0.5× 187 1.1× 121 0.9× 25 0.3× 6 609
Ze Cong United States 12 117 0.6× 57 0.3× 214 1.3× 36 0.3× 169 1.9× 44 455
Brittany A. Davidson United States 17 135 0.7× 55 0.3× 480 2.9× 111 0.8× 12 0.1× 90 1.2k
Brenda Bass Canada 8 71 0.4× 114 0.6× 144 0.9× 81 0.6× 20 0.2× 9 402

Countries citing papers authored by Michael Kolodziej

Since Specialization
Citations

This map shows the geographic impact of Michael Kolodziej's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kolodziej with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kolodziej more than expected).

Fields of papers citing papers by Michael Kolodziej

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kolodziej. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kolodziej. The network helps show where Michael Kolodziej may publish in the future.

Co-authorship network of co-authors of Michael Kolodziej

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kolodziej. A scholar is included among the top collaborators of Michael Kolodziej based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kolodziej. Michael Kolodziej is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolodziej, Michael, et al.. (2024). Symptoms reported by patients using an ePRO compared with those reported to nurses via telephone triage.. Journal of Clinical Oncology. 42(16_suppl). 1542–1542.
2.
3.
4.
Kolodziej, Michael, et al.. (2024). Private Payers and Cancer Care: Revisiting the Land of Opportunity. JCO Oncology Practice. 20(3). 318–322. 2 indexed citations
5.
Lee, Dah-Jye, et al.. (2017). Implementation of the IOM 13 point care plan by Oncology Care Model (OCM) practices.. Journal of Clinical Oncology. 35(15_suppl). e18279–e18279. 1 indexed citations
6.
Neubauer, Marcus A., et al.. (2016). A disease management pilot program in a Medicare-age population with cancer.. Journal of Clinical Oncology. 34(15_suppl). 6505–6505. 1 indexed citations
7.
Neubauer, Marcus A., et al.. (2016). Patient support call center: Interaction with the oncology clinic.. Journal of Clinical Oncology. 34(7_suppl). 84–84. 1 indexed citations
8.
Gräf, Klaus, Thomas Kohl, Bernd A. Neubauer, et al.. (2015). Percutaneous minimally invasive fetoscopic surgery for spina bifida aperta. Part III: neurosurgical intervention in the first postnatal year. Ultrasound in Obstetrics and Gynecology. 47(2). 158–161. 56 indexed citations
9.
Kolodziej, Michael, et al.. (2014). Private Payers and Cancer Care: Land of Opportunity. Journal of Oncology Practice. 10(1). 15–19. 5 indexed citations
10.
Fleming, Mark T., Guru Sonpavde, Michael Kolodziej, et al.. (2012). Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer. 10(1). 6–14. 23 indexed citations
11.
Hoverman, J. Russell, Thomas H. Cartwright, Debra A. Patt, et al.. (2011). Pathways, Outcomes, and Costs in Colon Cancer: Retrospective Evaluations in Two Distinct Databases. Journal of Oncology Practice. 7(3S). 52s–59s. 83 indexed citations
12.
Kolodziej, Michael, J. Russell Hoverman, Jody S. Garey, et al.. (2011). Benchmarks for Value in Cancer Care: An Analysis of a Large Commercial Population. Journal of Oncology Practice. 7(5). 301–306. 45 indexed citations
13.
Fleming, Mark T., Michael Kolodziej, Shivanshu Awasthi, et al.. (2010). Results of a randomized phase II study of mitoxantrone versus mitoxantrone with cetuximab in metastatic castrate-resistant prostate cancer (CRPC) previously treated with docetaxel-based chemotherapy.. Journal of Clinical Oncology. 28(15_suppl). 4555–4555. 2 indexed citations
14.
Neubauer, Marcus A., J. Russell Hoverman, Michael Kolodziej, et al.. (2010). Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting. Journal of Oncology Practice. 6(1). 12–18. 140 indexed citations
15.
Perrotti, Michael, et al.. (2008). Phase I/II trial of docetaxel and concurrent radiation therapy in localized high risk prostate cancer (AGUSG 03-10). Urologic Oncology Seminars and Original Investigations. 26(3). 276–280. 31 indexed citations
16.
Kolodziej, Michael. (2007). "Pues nosotros somos capaces...": reclamos indígenas en las fronteras abipón-santafesinas. Segunda mitad del siglo XVIII. PubMed. 20(12 Suppl). 273–300. 10 indexed citations
17.
Kolodziej, Michael, Marcus A. Neubauer, Steven R. Rousey, et al.. (2006). Phase II Trial of Docetaxel/Capecitabine in Hormone-Refractory Prostate Cancer. Clinical Genitourinary Cancer. 5(2). 155–161. 11 indexed citations
18.
Samlowski, Wolfram E., Danika L. Lew, Philip Kuebler, et al.. (1998). Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study. Investigational New Drugs. 16(3). 271–274. 6 indexed citations
19.
Kolodziej, Michael. (1993). Case Report: High-Dose Intravenous Immunoglobulin As Therapy for Thrombotic Thrombocytopenic Purpura. The American Journal of the Medical Sciences. 305(2). 101–102. 10 indexed citations
20.
Goldberger, Amy, Michael Kolodziej, Mortimer Poncz, JS Bennett, & PJ Newman. (1991). Effect of single amino acid substitutions on the formation of the PlA and Bak alloantigenic epitopes. Blood. 78(3). 681–687. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C.A. Uyl-de Groot Breakdown of academic impact, for papers by Thanh Ha Luu Breakdown of academic impact, for papers by Anna Forsythe Breakdown of academic impact, for papers by Sacha Satram‐Hoang Breakdown of academic impact, for papers by Dennis Cain Breakdown of academic impact, for papers by Miguel González Vélez Breakdown of academic impact, for papers by J.M. Jonker Breakdown of academic impact, for papers by Ze Cong Breakdown of academic impact, for papers by Brittany A. Davidson Breakdown of academic impact, for papers by Brenda Bass
Rankless by CCL
2026